12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Agrippal regulatory update

Novartis said the Italian Medicines Agency (AIFA) lifted its temporary halt on the use of the pharma's seasonal influenza vaccines Agrippal and Fluad following an independent assessment by AIFA of additional information the company provided. Novartis said distribution has already resumed in Canada, Switzerland and Singapore, and that it will continue to work with other countries to lift remaining precautionary measures.

Last month, EMA said a number of EU member states...

Read the full 338 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >